Stem cells provide a potent treatment for frailty Elderly people with frailty, which affects up to one-quarter of over-50s, increased their endurance after a single dose of stem cells. By Edward Chen

https://www.nature.com/articles/d41586-026-00584-y?utm_source=Live+Audience&utm_campaign=6e30f5dcf8-nature-briefing-daily-20260226&utm_medium=email&utm_term=0_-33f35e09ea-50432164

From no options to new hope: How science, partnership and persistence are driving progress towards treatments for CASK 26 February 2026

https://rarerevolutionmagazine.com/from-no-options-to-new-hope-how-science-partnership-and-persistence-are-driving-progress-towards-treatments-for-cask/ SPONSORED CONTENT -THIS ARTICLE HAS BEEN FUNDED AND WRITTEN BY THE OXFORD-HARRINGTON RARE DISEASE CENTRE Matthew Wood and Matthew P. Anderson of the Oxford-Harrington Rare Disease Centre (OHC) highlight their commitment to driving progress for rare disease—impacting the lives of families like Cynthia Schulz and her daughter Noni who spent decades living without answers or effective treatments for CASK Written by Matthew Wood, MD, PhD, director and chief scientific officer, and Matthew P. Anderson, MD, PhD, co-director of the Oxford-Harrington Rare Disease Centre

Most Read Cancer Science & Oncogenesis

https://read.qxmd.com/collection/1133?ecd=wnl_readmost_260227

Acute Complications of Myocardial Infarction Yasmine S. Ali, MD, MSCI | February 13, 2026 |

https://reference.medscape.com/slideshow/Complications-Myocardial-Infarction-6019213?ecd=wnl_critimg_260227_mscpref_etid8138590&uac=148436CN&impID=8138590

Navigating Cytopenias in Myelofibrosis: Tailoring Personalized Care for Optimal Outcomes Authors: Francesca Palandri, MD; Vikas Gupta, MD, FRCPath; Jennifer O'Sullivan, MD

https://www.medscape.org/viewarticle/navigating-cytopenias-myelofibrosis-tailoring-personalized-2026a10004km?page=1

Treating Metastatic Colorectal Cancer in the Second Line and Beyond: Oral Therapy Edition Authors: Rahul Gosain, MD, MBA; Rohit Gosain, MD; John Strickler, MD; Chiara Cremolini, MD, PhD

https://www.medscape.org/viewarticle/1003002?uac=148436CN&src=mkmcmr_driv_stan_mscpedu_260226-OUS-HONC-1003002-cta&sso=true

Zongertinib Picks Up First-Line Metastatic NSCLC Indication M. Alexander Otto, PA, MMSc February 27, 2026

https://www.medscape.com/viewarticle/zongertinib-picks-first-line-metastatic-nsclc-indication-2026a100066z